| Literature DB >> 29113271 |
Yuhao Dong1,2, Miaoyu Zeng3, Bin Zhang1,3, Lujun Han4, Entao Liu5, Zhouyang Lian1,3, Jing Liu1,3, Changhong Liang1, Shuixing Zhang1.
Abstract
The aim of the present study was to analyze the differences in imaging and clinical features between primary pulmonary lymphoma (PPL) and secondary pulmonary lymphoma (SPL) to provide insight into pulmonary lymphoma for an improved clinical diagnosis. A retrospective study of 38 patients with pulmonary lymphoma (19 PPL and 19 SPL) treated between September 1, 2006, and December 31, 2015, was performed. The clinical manifestations, and computed tomography (CT) and positron emission tomography-CT images of each case were collected. χ2 and Fisher's exact tests were applied to assess statistically significant differences between PPL and SPL in terms of clinical and imaging features. The significant variables were further applied to canonical discriminate analysis. The CT results revealed that the occurrence of a >3-cm mass (P=0.007), peripheral location (lower than the segmental bronchi) (P=0.027), cavitation (P=0.008) and consolidation (P=0.027) were associated with PPL, while peripheral and hilar location (P=0.003) or mediastinal and hilar lymph node engagement (P=0.044) were predominantly observed in SPL. However, no significant differences between clinical manifestations and the maximum standard uptake value of pulmonary lesions in PPL and SPL were identified (all P>0.05). A function derived from discriminate analysis was generated that may predict the affiliation to PPL or SPL radiographically, with an overall accuracy of ≤92.1%. The results of the present study revealed that PPL and SPL exhibit distinctive features on CT images due to distinct molecular mechanisms and growth patterns. Careful observation of CT features may be useful in the diagnosis of PPL and SPL regarding the tumor morphology, location and lymph node involvement.Entities:
Keywords: clinical features; computed tomography; diagnosis; discriminate analysis; primary pulmonary lymphoma; secondary pulmonary lymphoma
Year: 2017 PMID: 29113271 PMCID: PMC5661413 DOI: 10.3892/ol.2017.6962
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967